Francis Chou’s Favorite Stocks Include, Inc. (OSTK) and Dell Inc. (DELL)

In the year 1986, Chou Associates Management was founded by Francis Chou. He is a popular investor, with $650 million worth of assets under management, and the success of his bond fund is particularly notable. Moreover, he was named Morningstar’s Fund Manager of the Decade in 2004.

Francis ChouFrancis Chou had released his equity picks from Q2 via a 13F filing with the SEC. They are as follows: Berkshire Hathaway Inc. (NYSE:BRK.A), Resolute Forest Products Inc (NYSE:RFP), Dell Inc. (NASDAQ:DELL),, Inc. (NASDAQ:OSTK) and Sears Holdings Corp (NASDAQ:SHLD).

A longer look

Let’s take a longer look. Berkshire Hathaway Inc. (NYSE:BRK.A) remains in first place with a position worth $50.5 million. This is up from $46.8 million at the end of Q1, and the holding company led by Warren Buffett has seen its shares rise by 30.3% in 2013.

Following Berkshire Hathaway is Resolute Forest Products Inc (NYSE:RFP), with a total value of $49.3 million. Although it remains in the same spot as the previous quarter, it is found to have an increased value from $44.6 million. Dell Inc. (NASDAQ:DELL), likewise, also stays at number three and it has a value of $33.3 million in Chou’s 13F portfolio., Inc. (NASDAQ:OSTK) rises two spots to No. 4, as Chou and his team hold a $30.6 million position in the company. This is a slight increase from Q1, as shares of the online retailer have more than doubled in 2013 alone. Sears, the retailer that continues to struggle, still sits just in the top five of Chou’s equity portfolio, and shares are essentially flat this year.

To continue reading coverage of 13F season, check out one major investor’s picks below:

Seth Klarman’s Baupost Bought BP and Micron Last Quarter

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!